The effects of lauromacrogol injection into rat endometrial cysts: a preliminary experimental study

article OA: closed CC0 ⤵ 3 in-corpus citations
AI-generated summary by claude@2026-06+body, 2026-06-12

A 1% lauromacrogol injection significantly reduced endometrial cyst volumes and caused atrophy in a rat model, unlike a 0.5% concentration or no treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text

The study evaluated whether different concentrations of lauromacrogol injections reduce endometriosis-like lesions in a rat model, using autologous endometrial tissue transplantation to establish 40 endometrial cysts randomized to 1% lauromacrogol, 0.5% lauromacrogol, or untreated controls. Cyst changes were assessed by measuring cyst volumes and by comparing pre- and post-treatment lesion/implant volume, alongside histological examination of epithelia, glands, and surrounding stroma. The 1% concentration produced a statistically significant reduction in spherical volume with histopathological evidence of epithelial and gland atrophy and loose, edematous stromal tissue, whereas the 0.5% group showed no significant volume difference versus baseline. The paper’s main caveat is that it is described as preliminary, with an experimental basis aimed at pre-clinical application rather than established efficacy, and the abstract does not quantify sample sizes per group beyond the total. This paper is centrally about endometriosis — it tests lauromacrogol injections at different doses for regression of endometrial cysts in an experimental rat endometriosis model.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

ObjectiveTo determine the effectiveness of different concentrations of lauromacrogol injections for the treatment of endometriosis in an experimental animal model and to provide an experimental basis for a pre-clinical application of the drug.MethodsAfter autologous transplantation of endometrial tissue, 40 endometrial cysts were successfully established and randomly divided into three groups: a 1 % lauromacrogol injection group, a 0.5 % lauromacrogol injection group, and cysts without intervention (control group). We measured the changes in the volumes of the cysts in each group. We then compared the volumes of the endometrial implants before and after treatment and between the different groups and examined the histological findings.ResultsA significant difference in the spherical volume was found between the 1 % lauromacrogol injection group (P  0.05). Regarding the histopathological observations, in the 1 % lauromacrogol injection group, the epithelia of the cystic implants had atrophied, and the glands had atrophied and were reduced in number. The surrounding stromal tissue had become loose and edematous.ConclusionsA 1 % lauromacrogol injection produced significant regression of the endometrial foci compared with a 0.5 % lauromacrogol injection or no treatment in a rat model of endometriosis.
Full text 6,261 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Objective To determine the effectiveness of different concentrations of lauromacrogol injections for the treatment of endometriosis in an experimental animal model and to provide an experimental basis for a pre-clinical application of the drug.

Methods

After autologous transplantation of endometrial tissue, 40 endometrial cysts were successfully established and randomly divided into three groups: a 1 % lauromacrogol injection group, a 0.5 % lauromacrogol injection group, and cysts without intervention (control group). We measured the changes in the volumes of the cysts in each group. We then compared the volumes of the endometrial implants before and after treatment and between the different groups and examined the histological findings.

Results

A significant difference in the spherical volume was found between the 1 % lauromacrogol injection group (P 0.05). Regarding the histopathological observations, in the 1 % lauromacrogol injection group, the epithelia of the cystic implants had atrophied, and the glands had atrophied and were reduced in number. The surrounding stromal tissue had become loose and edematous.

Conclusions

A 1 % lauromacrogol injection produced significant regression of the endometrial foci compared with a 0.5 % lauromacrogol injection or no treatment in a rat model of endometriosis. Similar content being viewed by others

References

Fortin M, Lépine M, Pagé M et al (2003) An improved mouse model for endometriosis allows noninvasive assessment of lesion implantation and development. Fertil Steril 80(Suppl 2):832–838 Cayci T, Akgul EO, Kurt YG et al (2011) The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model. J Obstet Gynaecol Res 37:1041–1047 Yilmaz B, Kilic S, Aksakal O, Ertas IE et al (2015) Melatonin causes regression of endometriotic implants in rats by modulating angiogenesis, tissue levels of antioxidants and matrix metalloproteinases. Arch Gynecol Obstet 292(1):209–216 Taylor RN, Yu J, Torres PB et al (2009) Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 16:140–146 Song WW, Lu H, Hou WJ et al (2014) Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis. Int J Clin Exp Pathol. 7(11):7752–7759 Zhang Y, Cao H, Hu YY et al (2011) Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis. Int J Mol Med 27:87–94 Vernon MW, Wilson EA (1985) Studies on the surgical induction of endometriosis in the rat. Fertil Steril 44:684–694 Lebovic DI, Kir M, Casey CL (2004) Peroxisome proliferator-activated receptorgamma induces regression of endometrial explants in a rat model of endometriosis. Fertil Steril 82(Suppl 3):1008–1013 Yavuz E, Oktem M, Esinler I, Toru SA, Zeyneloglu HB (2007) Genistein causes regression of endometriotic implants in the rat model. Fertil Steril 88(4 Suppl):1129–1134 Zulfikaroglu E, Kılıc S, Islimye M et al (2011) Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model. Arch Gynecol Obstet 283:799–804 Yildirim G, Attar R, Ozkan F et al (2010) The effects of letrozole and melatonin on surgically induced endometriosis in a rat model: a preliminary study. Fertil Steril 93:1787–1792 Demirel MA, Suntar I, Ilhan M et al (2014) Experimental endometriosis remission in rats treated with Achillea biebersteinii Afan.: histopathological evaluation and determination of cytokine levels. Eur J Obstet Gynecol Reprod Biol 175:172–177 Uzunlar O, Ozyer S, Engin-Ustun Y et al (2014) Effects of repeated propranolol administration in a rat model of surgically induced endometriosis. Eur J Obstet Gynecol Reprod Biol 182:167–171 Cetinkaya N, Attar R, Yildirim G et al (2015) The effects of different doses of melatonin treatment on endometrial implants in an oophorectomized rat endometriosis model. Arch Gynecol Obstet 291(3):591–598 Bianconi L, Hummelshoj L, Coccia ME et al (2007) Recognizing endometriosis as a social disease: the European Union-encouraged Italian Senate approach. Fertil Steril 88:1285–1287 Chen X, Liu H, Feng L et al (2013) Effect of carbon dioxide pneumoperitoneal pressure on the ultrastructure of implanted endometriotic lesions in a rat model. Eur J Obstet Gynecol Reprod Biol 171(2):319–324 Olive DL, Pritts EA (2002) The treatment of endometriosis: a review of the evidence. Ann NY Acad Sci 955:360–372 Abbas MA, Taha MO, Disi AM et al (2013) Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis. Eur J Pharmacol 715(1–3):72–75 Patan S (2004) Vasculogenesis and angiogenesis. Cancer Treat Res 117:3–32 McLaren J (2000) Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 6:45–55 Pupo-Nogueira A, de Oliveira RM, Petta CA et al (2007) Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis. Int J Gynaecol Obstet 99:33–37 Machado DE, Berardo PT, Palmero CY et al (2010) Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1)and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases. J Exp Clin Cancer Res 29:4 Author information Authors and Affiliations Corresponding author Ethics declarations Funding This study was funded by the Shan Xi Tian Yu Pharmaceutical Co, LTD in China. Conflict of interest We declare that we have no conflict of interest. Ethical standards All experimental animals were handled in accordance with institutional and national guidelines for the care and use of laboratory animals. Additional information This study was completed as part of a master’s thesis at the Chinese PLA General Hospital. Rights and permissions About this article Cite this article Liu, W., Wang, L. & Guo, CX. The effects of lauromacrogol injection into rat endometrial cysts: a preliminary experimental study. Arch Gynecol Obstet 294, 555–559 (2016). https://doi.org/10.1007/s00404-016-4095-9 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-016-4095-9

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Cysts Polyethylene Glycols Uterine Diseases Animals Cysts Disease Models, Animal Endometriosis Endometriosis Female Humans Injections Polidocanol Polyethylene Glycols Rats Rats, Sprague-Dawley Uterine Diseases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (3)

Source provenance

europepmc
last seen: 2026-07-30T06:25:42.655704+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:21:07.355239+00:00
unpaywall
last seen: 2026-07-30T08:32:49.343555+00:00
License: CC0 · commercial use OK